STOCK TITAN

T Rowe Price Group Inc Form 4 Filings

TROW NASDAQ

Every Form 4 that T Rowe Price Group Inc (TROW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow TROW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TROW filings page.

Rhea-AI Summary

PRICE T ROWE GROUP INC (TROW) officer Joshua B. Nelson, a Vice President, reported mixed insider activity. On 2026-08-25, he sold 10,000 shares of common stock at a weighted-average price of $111.8203 per share, with actual sale prices ranging from $111.77 to $111.95. On the same date, he acquired 3.6582 shares of common stock at a weighted-average price of $101.0442 through the company’s Employee Stock Purchase Plan.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Sandra S. Wijnberg received an automatic share award through dividend reinvestment. On June 29, 2026, she acquired 147.8974 shares of Common Stock at a reference price of $114.38 per share. These fully vested shares were credited under the company’s 2017 Non-Employee Director Equity Plan in connection with dividends declared on the Common Stock. Following this routine, compensation-related acquisition, her direct holdings increased to 32,023.5921 shares of Common Stock.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Alan D. Wilson reported equity awards that increased his direct holdings. On June 30, he acquired 691 shares of Common Stock under the 2017 Non-Employee Director Equity Plan through dividend-related awards. On June 29, he received 462.1821 Stock Unit shares as Director Fee Awards. Following these grants, he directly holds 41,818.0935 Common Stock shares.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Richard R. Verma reported an automatic equity acquisition tied to dividends on company stock. On the transaction date, he acquired 54.9561 shares of Common Stock at a reference price of $114.38 per share under the 2017 Non-Employee Director Equity Plan. Following this award, his directly held stake rose to 4,890.2484 shares. The footnote explains that some shares are fully vested dividend reinvestment shares, while the remainder will vest when the related director equity grant vests.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Robert J. Stevens reported equity-based acquisitions of common stock, reflecting director compensation rather than open‑market trading. He acquired 537 shares on June 30, 2026, at a stated price of $0.00 per share, and 277.6811 shares on June 29, 2026 at $114.38 per share. According to the company’s 2017 Non-Employee Director Equity Plan, the June 30 activity relates to dividends on existing awards, partly as fully vested dividend reinvestment shares and partly as amounts that will vest with the underlying grant. A footnote explains that stock units for director fee awards were issued at $113.69 per share, the closing TROW price on June 30, 2026, and will vest in full on the grant date. After these transactions, Stevens directly holds 25,246.3461 common shares.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Cynthia F. Smith reported an automatic share acquisition tied to dividends on the company’s Common Stock. She received 69.9053 shares at a reference price of $114.38 per share under the 2017 Non-Employee Director Equity Plan. Following this grant and dividend reinvestment, she directly holds 8,698.4992 Common Stock shares, with some of the new shares fully vested and others scheduled to vest when the related director grant vests.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Robert F. MacLellan reported equity awards rather than open-market trades. On June 30, 2026, he acquired 658 Common Stock shares at $0.00 per share under the 2017 Non-Employee Director Equity Plan, tied to dividends on Common Stock. On June 29, 2026, he received 184.5531 Common Stock shares at $114.38 per share as a director fee-related award. Footnotes explain these arise from dividend reinvestment and Stock Units issued at $113.69 per share for Director Fee Awards, which vest in full on the grant date. Following these awards, MacLellan directly holds 55,707.3847 shares of Price T Rowe Common Stock.

Rhea-AI Summary

Golston Allan C. reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director equity grant: Non-employee director Allan C. Golston received an award of 54.9561 shares of Common Stock on account of dividends declared under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan. The shares will accrue and vest when the corresponding grant vests. Following this award, Golston directly holds a total of 4,890.2484 shares of Common Stock.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Dina Dublon received additional common shares through a dividend-related equity award. On the relevant date, she acquired 108.8196 shares of common stock at $114.38 per share, credited as fully vested dividend reinvestment shares under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan.

After this grant, Dublon directly holds 15,533.2737 common shares. Separately, The Dina Dublon Family Trust indirectly holds 1,890 common shares, reflecting an additional ownership position held through a family trust.

Rhea-AI Summary

PRICE T ROWE GROUP INC director William P. Donnelly reported equity awards rather than open-market trades. On June 30, 2026, he acquired 576 Common Stock shares pursuant to the 2017 Non-Employee Director Equity Plan, tied to dividends on the company’s common stock.

On June 29, 2026, he also acquired 141.6845 Common Stock shares as director fee-related stock units. Following these awards, Donnelly directly holds 13,183.7445 Common Stock shares. These transactions reflect compensation and dividend reinvestment mechanisms, not discretionary market purchases.

Rhea-AI Summary

Page Sebastien reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC vice president Sebastien Page reported an equity compensation grant of 96,228 shares of Common Stock at a price of $0.00 per share. This award increases his direct holdings to 171,855 shares after the transaction.

The grant is in the form of restricted stock units that are settled in common stock upon vesting. According to the disclosure, the award vests in five equal annual installments beginning on June 1, 2027, providing a long-term incentive that ties compensation to future company performance.

Rhea-AI Summary

PRICE T ROWE GROUP INC Vice President Stephon A. Jackson reported mixed common stock transactions. He sold 3,000 shares in an open-market sale at $102.56 per share. Separately, he acquired 175.3519 shares at a weighted-average price of $98.0796 through the Employee Stock Purchase Plan. After the reported sale transaction, he directly held 83,882.5334 shares of common stock.

Rhea-AI Summary

WILSON ALAN D reported acquisition or exercise transactions in this Form 4 filing.

Alan D. Wilson, a director of PRICE T ROWE GROUP INC, received a grant of 1,899 shares of common stock as a restricted stock unit award under the 2017 Non-Employee Director Equity Plan at $105.33 per share. His direct holdings increased to 40,664.9114 shares, with vesting tied to service, death, disability, or a change in control.

Rhea-AI Summary

WIJNBERG SANDRA S reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director Sandra S. Wijnberg received a grant of 1,899 shares of common stock as equity compensation. The restricted award was issued at $105.33 per share under the 2017 Non-Employee Director Equity Plan and increased her direct holdings to about 31,876 shares.

The award and accrued dividends will fully vest and become nonforfeitable upon the earliest of several events, including the day immediately prior to the next year’s annual meeting, death, determination of total and permanent disability, or a change in control, when vesting would occur immediately before that event.

Rhea-AI Summary

Verma Richard R. reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director Richard R. Verma reported receiving an equity award in the form of 1,899 shares of Common Stock on May 8, 2026. The award is tied to the company’s 2017 Non-Employee Director Equity Plan and was issued at $105.33 per share, matching the closing price that day.

The restricted stock unit shares and related dividends are subject to forfeiture until they vest. Vesting occurs in full upon the earliest of several events, including the day immediately prior to the next year’s Annual Meeting, death, a determination of Total and Permanent Disability, or a Change in Control. Following this grant, Verma directly holds about 4,835.2923 shares of the company’s stock.

Rhea-AI Summary

STEVENS ROBERT J reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director Robert J. Stevens received an equity award of 1,899 restricted stock unit shares under the 2017 Non-Employee Director Equity Plan. The award was granted at $105.33 per share and increases his direct holdings to 24,431.665 shares of common stock.

The restricted stock unit shares and accrued dividends will vest in full upon the earlier of next year’s annual meeting, his death, a determination of total and permanent disability, or immediately before a qualifying change in control.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Cynthia F. Smith received an equity award of 1,899 shares of common stock. The grant is coded as a compensation-related acquisition with no cash paid per share. The award was valued using a share price of $105.33 under the 2017 Non-Employee Director Equity Plan and is structured as restricted stock unit shares that vest upon specific events, including the day before the next annual meeting, death, total and permanent disability, or a change in control. Following this grant, Smith directly holds a total of 8,628.5939 shares.

Rhea-AI Summary

Rominger Eileen P reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director Eileen P. Rominger received a stock grant of 1,899 common shares on May 8, 2026. The award was issued at $105.33 per share under the 2017 Non-Employee Director Equity Plan as restricted Award Shares, with no cash paid by the director.

After this grant, Rominger directly holds 10,867 common shares. The restricted Award Shares and related accrued dividends vest in full upon the earlier of the next year’s annual meeting, death, a determination of Total and Permanent Disability, or immediately before a Change in Control.

Rhea-AI Summary

MacLellan Robert F. reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director Robert F. MacLellan received an equity award of 1,899 shares of common stock in the form of restricted stock units under the 2017 Non-Employee Director Equity Plan. The units were issued at $105.33 per share, matching the TROW share closing price on May 8, 2026, and were granted at no cash cost to him. These stock unit shares and related accrued dividends will fully vest upon the earliest of the first anniversary of the grant date, death, a determination of Total and Permanent Disability, or immediately before a Change in Control. Following this grant, MacLellan directly holds a total of 54,864.8316 shares of TROW common stock.

Rhea-AI Summary

Golston Allan C. reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director Allan C. Golston reported receiving an equity award of 1,899 shares of Common Stock with no cash paid per share. This award increased his directly held position to 4,835.2923 shares.

The footnote explains that these shares relate to Restricted Stock Units granted under the 2017 Non-Employee Director Equity Plan at a reference price of $105.33 per share, with vesting contingent on service through the next annual meeting or upon specified events such as death, total and permanent disability, or a change in control.

Rhea-AI Summary

DUBLON DINA reported acquisition or exercise transactions in this Form 4 filing.

Price T Rowe Group director Dina Dublon received 1,899 shares of restricted common stock as a grant under the 2017 Non-Employee Director Equity Plan. The award is valued at $105.33 per share and vests in full by the next annual meeting or earlier upon death, total and permanent disability, or a change in control. After this grant, she holds 15,424.4541 shares directly and 1,890 shares indirectly through The Dina Dublon Family Trust.

Rhea-AI Summary

BARTLETT MARK S. reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director equity award: Director Mark S. Bartlett received a grant of 1,899 shares of common stock on May 8, 2026 under the 2017 Non-Employee Director Equity Plan at a reference price of $105.33 per share. After this award, he directly holds 35,263 common shares. These restricted shares, along with accrued dividends, will vest in full upon the earlier of the day immediately prior to the next year’s annual meeting, the director’s death, a determination of total and permanent disability, or a change in control, when vesting would occur immediately before and contingent on that event.

Rhea-AI Summary

DONNELLY WILLIAM P reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director William P. Donnelly received a stock award of 1,899 common shares. The shares were granted on May 8, 2026 as a compensation-related award at a reference price of $105.33 per share under the 2017 Non-Employee Director Equity Plan.

Following this grant, Donnelly directly holds a total of 12,466.06 common shares. The restricted stock unit shares, along with related dividends, will fully vest upon the earliest of several events, including the next annual meeting, death, total and permanent disability, or a change in control.

Rhea-AI Summary

WILSON ALAN D reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director Alan D. Wilson received an equity award of 557.9064 shares of Common Stock, valued at $89.03 per share. The award was made under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan and relates to dividends declared on the company’s Common Stock.

A portion of these shares was credited as fully vested dividend reinvestment shares, while the remainder will accrue and vest when the corresponding grant vests. Following this award, Wilson directly holds a total of 38,765.9114 shares of Common Stock.

Rhea-AI Summary

T. Rowe Price Group director Sandra S. Wijnberg acquired additional common stock through a share award. She received 187.2745 shares of Common Stock at $89.03 per share as a grant or other acquisition, bringing her direct holdings to 29,976.6947 shares.

According to the footnote, the shares were credited as fully vested dividend reinvestment shares under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan in connection with dividends declared on the issuer’s common stock.

Rhea-AI Summary

Verma Richard R. reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director Richard R. Verma received a grant of 42.2582 shares of Common Stock valued at $89.0300 per share. The award was made under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan as dividend equivalents that will accrue and vest when the corresponding grant vests. Following this award, Verma directly holds a total of 2936.2923 shares of Common Stock.

Rhea-AI Summary

STEVENS ROBERT J reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director Robert J. Stevens received a grant of 324.2828 shares of Common Stock, valued at $89.03 per share. The award was made under the company’s 2017 Non-Employee Director Equity Plan as dividend-related stock compensation. Following this transaction, he directly holds 22,532.6650 shares.

Rhea-AI Summary

Smith Cynthia F reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC director Cynthia F. Smith received 61.1876 shares of Common Stock as a grant tied to dividends. The shares were valued at $89.03 per share on the transaction date and increased her directly held position to 6,729.5939 shares.

The award was made under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan in connection with dividends declared on the company’s Common Stock. According to the disclosure, part of the award consists of fully-vested dividend reinvestment shares, while the remaining portion will vest when the related underlying director grant vests.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Robert F. MacLellan acquired 206.3598 shares of Common Stock as a fully vested grant under the company’s 2017 Non-Employee Director Equity Plan, tied to dividends on the stock. The shares were credited as dividend reinvestment, bringing his direct holdings to 52,965.8316 shares.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Allan C. Golston acquired additional common stock through a compensation grant. He received 42.2582 shares of common stock valued at $89.03 per share, credited as dividend equivalents under the 2017 Non-Employee Director Equity Plan. After this award, his direct holdings total 2,936.2923 shares.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Dina Dublon received a stock award credited as fully-vested dividend reinvestment shares under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan. She acquired 137.7924 shares of Common Stock at $89.03 per share on March 30, 2026.

After this award, Dublon directly holds 13,525.4541 Common Stock shares. An additional 1,890.0000 shares are held indirectly through The Dina Dublon Family Trust, reflecting a separate indirect ownership position reported as a holding entry.

Rhea-AI Summary

PRICE T ROWE GROUP INC director William P. Donnelly reported an acquisition of Common Stock through an equity plan–related dividend award. He received 152.0777 shares at a reference price of $89.03 per share, bringing his direct holdings to 10,567.0600 shares.

According to the disclosure, this transaction occurred under the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan in connection with dividends declared on the company’s Common Stock. A portion of the shares was credited as fully-vested dividend reinvestment shares, while the remainder will accrue and vest when the corresponding equity grant vests.

Rhea-AI Summary

PRICE T ROWE GROUP INC director Robert F. MacLellan exercised stock options and acquired 4,417 shares of common stock on February 26, 2026. The options were exercised at a price of $74.1408 per share, increasing his directly held common stock to about 52,759 shares.

Rhea-AI Summary

Page Sebastien reported acquisition or exercise transactions in this Form 4 filing.

PRICE T ROWE GROUP INC vice president Page Sebastien reported an equity award of 8,861 shares of common stock on February 13, 2026, as a performance-based grant at a price of $0.00 per share. After this award, Sebastien directly holds 75,627 common shares.

The award reflects that the Executive Compensation and Management Development Committee certified that performance thresholds on certain performance-based restricted stock awards were met. These awards will be settled in common shares upon vesting and will vest in two equal annual installments beginning on December 10, 2026.

Rhea-AI Summary

Veiel Eric L reported acquisition or exercise transactions in a Form 4 filing for TROW. The filing lists transactions totaling 13,151 shares at a weighted average price of $103.93 per share. Following the reported transactions, holdings were 133,944 shares.

Rhea-AI Summary

Robert W. Sharps reported acquisition or exercise transactions in a Form 4 filing for TROW. The filing lists transactions totaling 22,404 shares at a weighted average price of $103.92 per share. Following the reported transactions, holdings were 556,007 shares.

Rhea-AI Summary

Dardis Jennifer B reported acquisition or exercise transactions in a Form 4 filing for TROW. The filing lists transactions totaling 5,604 shares at a weighted average price of $104.05 per share. Following the reported transactions, holdings were 40,751 shares.

Rhea-AI Summary

T. Rowe Price Group, Inc. executive Dorothy C. Sawyer, listed as VP, reported two common stock transactions dated February 5, 2026. She transferred 5,154.945 shares of common stock at a price of $0.00 per share, then acquired 32.3317 shares at $104.10 per share.

The footnote states the 32.3317 shares were acquired through the T. Rowe Price Group, Inc. Employee Stock Purchase Plan at the noted weighted-average price. Following these transactions, she directly held 55,641.9683 shares of common stock.

Rhea-AI Summary

Price T Rowe Group Inc. insider David Oestreicher, who serves as Corporate Secretary and Vice President, reported a change in his holdings of the company’s common stock. On 12/17/2025, he transferred 400 shares of common stock in a transaction coded "G," indicating a gift, at a reported price of $0.00 per share. Following this transaction, he beneficially owns 129,466.8177 shares of Price T Rowe Group Inc. common stock, held directly.

Rhea-AI Summary

Price T Rowe Group Inc. vice president Eric L. Veiel reported a disposition of 1,000 shares of common stock on 12/15/2025, using transaction code "G" at a stated price of $0.00 per share.

Following this insider transaction, he beneficially owned 138,020.4419 shares of Price T Rowe Group common stock in direct ownership, according to the filing.

Rhea-AI Summary

Price T Rowe Group reported an insider stock transaction by a company vice president. On 12/10/2025, the officer disposed of 3,150 shares of common stock at $105.37 per share in a transaction coded F. After this, the insider directly beneficially owned 60,764.5816 shares of the company’s common stock.

Rhea-AI Summary

A vice president of PRICE T ROWE GROUP INC reported a disposition of 7,843 shares of common stock at $105.37 per share on 12/10/2025. Following this code F transaction, the officer directly beneficially owned 66,766 shares of the company’s common stock.

Rhea-AI Summary

PRICE T ROWE GROUP INC officer Arif Husain reported selling 4,260 shares of common stock on December 10, 2025 at an average price of $101.9567 per share.

After this transaction, he beneficially owns 47,102.4602 shares, held directly. The filing notes the sale took place within a price range of $101.72 to $102.12, and no derivative security transactions were reported.

Rhea-AI Summary

Price T Rowe Group Inc reported an insider equity award for a company officer. A vice president received 10,234 shares of common stock on 12/03/2025 at a price of $0.00, reflecting settlement of a restricted stock unit grant. Following this award, the officer directly beneficially owns 74,609 shares of common stock.

The filing explains that this restricted stock unit award will be settled in shares of common stock as it vests. The award vests in three annual installments beginning on December 10, 2026. In addition, as described in the company’s 2019 proxy statement, the officer also holds a separate performance-based award that, if earned, would vest in two annual installments beginning on December 10, 2029.

Rhea-AI Summary

T. Rowe Price Group corporate secretary and VP David Oestreicher reported acquiring additional company stock. On 12/03/2025, he received a restricted stock unit (RSU) award covering 12,138 shares, which vests 20% annually over five years beginning on 12/10/2026. He also acquired 218.4376 shares of common stock through the T. Rowe Price Group, Inc. Employee Stock Purchase Plan at a weighted-average price of $100.4322. After these transactions, he directly owned 132,656.8177 shares of T. Rowe Price common stock.

Rhea-AI Summary

T. Rowe Price Group vice president Joshua Nelson reported several stock transactions dated December 3, 2025. He acquired 9,996 shares of common stock at $0.00 as a restricted stock unit award that will be settled in shares of common stock upon vesting.

The time-based award vests in three annual installments beginning on December 10, 2026, and he also has a performance-based award that, if earned, would vest in two annual installments beginning on December 10, 2029. He additionally bought 4.349 shares through the employee stock purchase plan at a weighted-average price of $99.9977 and made a gift of 654 shares, leaving him with 87,640.273 shares owned directly.

Rhea-AI Summary

T. Rowe Price Group vice president Stephon A. Jackson increased his direct holdings of common stock through equity awards and an employee stock purchase. On December 3, 2025, he received 8,806 shares at no cost from a restricted stock unit award that is settled in shares of common stock upon vesting, and acquired 438.4752 shares at a weighted-average price of $100.8445 under the T. Rowe Price Group, Inc. Employee Stock Purchase Plan. These transactions brought his directly held common stock position to 94,984.4675 shares. The restricted stock unit award vests in three annual installments beginning on December 10, 2026, and he also holds a separate performance-based award that, if earned, would vest in two annual installments beginning on December 10, 2029.

Rhea-AI Summary

T. Rowe Price Group reported that company officer Jessica M. Hiebler, Principal Accounting Officer, acquired additional common stock. On 12/03/2025 she received 953 restricted stock units at a price of $0.00, which vest 20% annually over a five-year period beginning on 12/10/2026. The same day she acquired 263.5568 common shares through the T. Rowe Price Group, Inc. Employee Stock Purchase Plan at a weighted-average price of $100.0349 per share. Following these transactions, she beneficially owned 14,827.953 shares of T. Rowe Price Group common stock, held directly.

Rhea-AI Summary

T. Rowe Price Group, Inc. (TROW) CEO and President Robert W. Sharps reported routine changes in his holdings of company stock. On 11/24/2025, he acquired 523.0932 shares of common stock at a weighted-average price of $97.0036 through the company’s Employee Stock Purchase Plan. On the same date, he disposed of 2,500 shares in a transaction coded as a gift at $0.00. Following these transactions, he beneficially owned 540,528.6509 shares of T. Rowe Price common stock, held directly.

Rhea-AI Summary

T. Rowe Price (TROW) disclosed an insider transaction on Form 4. A director acquired 2,859 shares of common stock on 10/28/2025 at a reported price of $0.00. After this transaction, the director directly holds 2,859 shares. No derivative securities were reported in the filing.